{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:52:03Z","timestamp":1781596323797,"version":"3.54.5"},"reference-count":27,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The objective of this population-based study was to identify factors associated with insulin pump therapy initiation in adults with insulin-requiring diabetes in France in 2015.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>People with insulin-requiring diabetes and their characteristics were identified from the national health data system. Factors associated with insulin pump therapy initiation were identified by logistic regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study focused on 614,913 adults with diabetes treated by multiple daily injections before 2015: 4083 of them initiated insulin pump therapy during the year (71% of them had type 1 diabetes, T1D). Factors associated with insulin pump therapy initiation were the number of consultations with an endocrinologist within the past 2 years (2 vs. 0, odds ratio [OR]\u2009=\u20091.5,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.01), the presence of a chronic cardiovascular or neurovascular disease (OR\u2009=\u20091.6 for T1D, OR\u2009=\u20091.3 for type 2 diabetes [T2D],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and treatment with antidepressants\/anxiolytics (OR\u2009=\u20091.2 for T1D, OR\u2009=\u20091.4 for T2D,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.01). The other determinants were female gender (OR\u2009=\u20091.5,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and history of hospitalization for acute metabolic complications (OR\u2009=\u20091.14,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.01) in T1D. Factors associated with less insulin pump therapy initiation were age, duration of diabetes, end-stage renal disease, and social deprivation (OR\u2009=\u20090.662,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.01, T1D only).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Predictive factors of insulin pump therapy initiation in people with insulin-requiring diabetes in 2015 in France were globally consistent with clinical practice guidelines. Age, male gender, and social deprivation are still associated with a lower rate of insulin pump therapy initiation in adults with T1D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/dia.2020.0112","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T23:31:56Z","timestamp":1591831916000},"page":"8-19","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Age, Male Gender, and Social Deprivation Are Associated with a Lower Rate of Insulin Pump Therapy Initiation in Adults with Type 1 Diabetes: A Population-Based Study"],"prefix":"10.1177","volume":"23","author":[{"given":"Lise","family":"Meunier","sequence":"first","affiliation":[{"name":"CNAM (Caisse Nationale d'Assurance Maladie), French National Health Insurance, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Aguad\u00e9","sequence":"additional","affiliation":[{"name":"CNAM (Caisse Nationale d'Assurance Maladie), French National Health Insurance, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Videau","sequence":"additional","affiliation":[{"name":"ERUDITE (Research Team on the Use of Individual Data related to Economic Theory). University of Paris-Est Cr\u00e9teil, Cr\u00e9teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"Verboux","sequence":"additional","affiliation":[{"name":"CNAM (Caisse Nationale d'Assurance Maladie), French National Health Insurance, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fagot-Campagna","sequence":"additional","affiliation":[{"name":"CNAM (Caisse Nationale d'Assurance Maladie), French National Health Insurance, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Gastaldi-Menager","sequence":"additional","affiliation":[{"name":"CNAM (Caisse Nationale d'Assurance Maladie), French National Health Insurance, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Amadou","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, University of Paris-Saclay and Sud-Francilien Hospital, Corbeil-Essonnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,12,31]]},"reference":[{"key":"e_1_3_5_2_2","unstructured":"French National Health Insurance (ameli.fr). Rapports Charges et produits pour les ann\u00e9es 2018 \u00e0 2020. https:\/\/www.ameli.fr\/l-assurance-maladie\/statistiques-et-publications\/rapports-et-periodiques\/rapports-charges-produits-de-l-assurance-maladie\/rapports-charges-et-produits-pour-2018-a-2020\/rapport-charges-et-produits-pour-l-annee-2018.php (accessed March9 2020)."},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2009.09.002"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2201"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61037-0"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpped.2015.06.011"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.12.009"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1987.tb03360.x"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02486.x"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00271261"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2017-0234"},{"key":"e_1_3_5_12_2","first-page":"j1285","article-title":"Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE)","volume":"356","author":"The REPOSE Study group","year":"2017","unstructured":"The REPOSE Study group. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ, 2017; 356:j1285.","journal-title":"BMJ"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP12104.OR"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.09.028"},{"key":"e_1_3_5_15_2","article-title":"Quality of life in patients treated with insulin pump compared with MDI in Croatia","author":"Bilic-Curcic I","unstructured":"Bilic-Curcic I, , Vukojevic V, , Gradiser M, , Berkovic MC: Quality of life in patients treated with insulin pump compared with MDI in Croatia. Diabetes 2018 Jul; 67 (Supplement 1):2278-PUB.","journal-title":"Diabetes"},{"key":"e_1_3_5_16_2","unstructured":"Chevreul K Berg Brigham K Durand-Zaleski I Hern\u00e1ndez-QuevedoHealth C: France: Health system review. Health Syst Transit 2015;17. www.euro.who.int\/en\/about-us\/partners\/observatory\/publications\/health-system-reviews-hits\/full-list-of-country-hits\/france-hit-2015"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2017.05.004"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-018-1024-9"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2017.1267138"},{"key":"e_1_3_5_20_2","first-page":"87","article-title":"Measuring social inequalities in mortality by cause of death. Ecological approach based on a social deprivation index","author":"Rey G","year":"2011","unstructured":"Rey G, , Rican S, , Jougla E: Measuring social inequalities in mortality by cause of death. Ecological approach based on a social deprivation index. Bull Epidemiol Hebd, 2011:87\u201390.","journal-title":"Bull Epidemiol Hebd"},{"key":"e_1_3_5_21_2","unstructured":"French national health insurance. Couverture maladie universelle compl\u00e9mentaire (Complementary universal health coverage); donn\u00e9es et statistiques. https:\/\/www.ameli.fr\/l-assurance-maladie\/statistiques-et-publications\/donnees-statistiques\/couverture-maladie-universelle-cmu.php"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-016-0794-1"},{"key":"e_1_3_5_23_2","unstructured":"National Diabetes Insulin Pump Audit. National Diabetes Insulin Pump Audit: what are the outcomes for people using an insulin pump? A summary report of the National Diabetes Insulin Pump Audit for England and Wales 2016\u20132017. https:\/\/www.diabetes.org.uk\/resources-s3\/2018\u201312\/Insulin_%20Summary_v4.pdf"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.04.042"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816650209"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2015.0165"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.4127"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2008.11.012"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2020.0112","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2020.0112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2020.0112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:12:45Z","timestamp":1777399965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2020.0112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1089\/dia.2020.0112"],"URL":"https:\/\/doi.org\/10.1089\/dia.2020.0112","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,31]]}}}